10/9/2026
FDA faces internal dissent over HHS peptide legalization
HHS plans to allow unapproved peptides, sparking FDA staff concerns.
Topic archive
drug regulation
8 stories
10/7/2026
FDA proposes strict ibogaine trial guidelines
Public input sought on inpatient care and heart monitoring
10/6/2026
FDA seeks public input on ibogaine clinical trials
Public comments sought on trial design, dosing, and safety for ibogaine studies.
9/22/2026
Ibogaine treatment and the case of Presley Gerber
Presley Gerber's use of ibogaine highlights its controversial role in addiction treatment.
9/21/2026
Ibogaine gains attention for addiction treatment
Psychedelic compound ibogaine draws interest amid regulatory shifts.
8/27/2026
Costa Rica psychedelic retreats under scrutiny after tourist death
American tourist's death highlights risks of unregulated psychedelic retreats in Costa Rica.
8/12/2026
UC Irvine explores ibogaine for opioid addiction
Researchers at UC Irvine investigate ibogaine's potential in opioid use disorder treatment.
8/6/2026
Ibogaine use linked to sudden death in Canada
Police arrest man in Mississauga following ibogaine-related death investigation.